 |
市場調查報告書
商品編碼
1991424
重組C因子檢測全球市場規模、佔有率、趨勢及成長分析報告（2026-2034年）Global Recombinant Factor C Assay Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
預計重組因子 C 檢測市場將從 2025 年的 2.0937 億美元成長到 2034 年的 6.2745 億美元，2026 年至 2034 年的複合年成長率為 12.97%。
隨著各行業對更可靠、更符合倫理的內毒素檢測方法的需求日益成長，全球重組因子C檢測市場正在擴張。重組因子C檢測用於檢測藥品、醫療設備和生物技術產品中的細菌內毒素。與依賴鱟血的傳統方法不同，此檢測採用重組技術，提供永續且穩定的檢測方案。人們對環境保護和符合倫理的檢測方法的日益關注，正在推動這項技術的應用。
市場成長的關鍵促進因素是製藥和生物技術產業的蓬勃發展，這些產業對生產過程的品管要求極高。監管機構正將精準的內毒素檢測作為優先事項，以確保注射劑和醫療設備的安全。由於重組C因子檢測具有更高的靈敏度和可重複性，因此對於尋求可靠檢測方案的檢查室，其正成為越來越有吸引力的選擇。
隨著越來越多的公司向永續檢測技術轉型，該市場前景一片光明。監管機構對基於重組技術的檢測方法的認可度不斷提高，預計將進一步加速其在製藥生產設施中的應用。檢測性能和檢查室自動化的持續改進可望進一步提升效率。隨著環保意識和產品安全標準的不斷發展，重組因子C檢測方法有望在整個產業中獲得更廣泛的認可。
目錄
第1章：引言
第2章執行摘要
第3章 市場變數、趨勢與框架
- 市場譜系展望
- 滲透率和成長前景分析
- 價值鏈分析
- 法律規範
- 標準與合規性
- 監管影響分析
- 市場動態
- 市場促進因素
- 市場限制因素
- 市場機遇
- 市場挑戰
- 波特五力分析
- PESTLE分析
第4章 全球重組C因子檢測市場：依產品類型分類
- 市場分析、洞察與預測
- 成套工具
- 試劑
- 裝置
第5章 全球重組C因子檢測市場：依應用分類
- 市場分析、洞察與預測
- 內毒素試驗
- 藥物研發
- 疫苗生產
- 其他
第6章 全球重組C因子檢測市場：依最終用戶分類
- 市場分析、洞察與預測
- 製藥和生物技術公司
- 受託研究機構
- 學術研究機構
第7章 全球重組C因子檢測市場：按地區分類
- 區域分析
- 北美市場分析、洞察與預測
- 美國
- 加拿大
- 墨西哥
- 歐洲市場分析、洞察與預測
- 英國
- 法國
- 德國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太市場分析、洞察與預測
- 印度
- 日本
- 韓國
- 澳洲
- 東南亞
- 其他亞太國家
- 拉丁美洲市場分析、洞察與預測
- 巴西
- 阿根廷
- 秘魯
- 智利
- 其他拉丁美洲國家
- 中東和非洲市場分析、洞察與預測
- 沙烏地阿拉伯
- UAE
- 以色列
- 南非
- 其他中東和非洲國家
第8章 競爭情勢
- 最新趨勢
- 公司分類
- 供應鏈和銷售管道合作夥伴（根據現有資訊）
- 市場佔有率和市場定位分析（基於現有資訊）
- 供應商情況（基於現有資訊）
- 策略規劃
第9章：公司簡介
- 主要公司的市佔率分析
- 公司簡介
- Thermo Fisher Scientific Inc
- Lonza Group AG
- WuXi AppTec Co. Ltd
- Merck KGaA
- Charles River Laboratories International Inc
- Sartorius AG
- Eurofins Scientific
- GenScript Biotech Corporation
- Agilent Technologies Inc
- PerkinElmer Inc
- Tecan Group Ltd
- Bio-Rad Laboratories Inc
- Beckman Coulter Inc
- Abcam Plc
- Hycult Biotech
The Recombinant Factor C Assay Market size is expected to reach USD 627.45 Million in 2034 from USD 209.37 Million (2025) growing at a CAGR of 12.97% during 2026-2034.
The global recombinant factor C assay market has expanded as industries seek more reliable and ethical alternatives for endotoxin detection. Recombinant factor C assays are used to detect bacterial endotoxins in pharmaceuticals, medical devices, and biotechnology products. Unlike traditional testing methods that rely on horseshoe crab blood, this assay uses recombinant technology to provide a sustainable and consistent testing solution. Growing concerns about environmental conservation and ethical testing practices have strengthened the adoption of this technology.
Key drivers of market growth include the expanding pharmaceutical and biotechnology industries, which require strict quality control during manufacturing processes. Regulatory authorities emphasize accurate endotoxin testing to ensure the safety of injectable drugs and medical devices. Recombinant factor C assays offer improved sensitivity and reproducibility, making them increasingly attractive to laboratories seeking reliable testing solutions.
The future of this market appears highly positive as more companies transition toward sustainable testing technologies. Increasing regulatory acceptance of recombinant-based assays is expected to encourage broader adoption across pharmaceutical manufacturing facilities. Continuous improvements in assay performance and laboratory automation may further enhance efficiency. As environmental awareness and product safety standards continue to evolve, recombinant factor C assays are likely to gain wider industry acceptance.
MARKET SEGMENTATION
By Product Type
- Kits
- Reagents
- Instruments
By Application
- Endotoxin Testing
- Drug Development
- Vaccine Production
- Others
By End User
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations
- Academic and Research Institutes
COMPANIES PROFILED
- Thermo Fisher Scientific Inc, Lonza Group AG, WuXi AppTec Co Ltd, Merck KGaA, Charles River Laboratories International Inc, Sartorius AG, Eurofins Scientific, GenScript Biotech Corporation, Agilent Technologies Inc, PerkinElmer Inc, Tecan Group Ltd, BioRad Laboratories Inc, Beckman Coulter Inc, Abcam plc, Hycult Biotech
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL RECOMBINANT FACTOR C ASSAY MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Product Type
- 4.2. Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL RECOMBINANT FACTOR C ASSAY MARKET: BY APPLICATION 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Application
- 5.2. Endotoxin Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Drug Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Vaccine Production Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL RECOMBINANT FACTOR C ASSAY MARKET: BY END USER 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast End User
- 6.2. Pharmaceutical and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Academic and Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL RECOMBINANT FACTOR C ASSAY MARKET: BY REGION 2022-2034 (USD MN)
- 7.1. Regional Outlook
- 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.2.1 By Product Type
- 7.2.2 By Application
- 7.2.3 By End User
- 7.2.4 United States
- 7.2.5 Canada
- 7.2.6 Mexico
- 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.3.1 By Product Type
- 7.3.2 By Application
- 7.3.3 By End User
- 7.3.4 United Kingdom
- 7.3.5 France
- 7.3.6 Germany
- 7.3.7 Italy
- 7.3.8 Russia
- 7.3.9 Rest Of Europe
- 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.4.1 By Product Type
- 7.4.2 By Application
- 7.4.3 By End User
- 7.4.4 India
- 7.4.5 Japan
- 7.4.6 South Korea
- 7.4.7 Australia
- 7.4.8 South East Asia
- 7.4.9 Rest Of Asia Pacific
- 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.5.1 By Product Type
- 7.5.2 By Application
- 7.5.3 By End User
- 7.5.4 Brazil
- 7.5.5 Argentina
- 7.5.6 Peru
- 7.5.7 Chile
- 7.5.8 Rest of Latin America
- 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 7.6.1 By Product Type
- 7.6.2 By Application
- 7.6.3 By End User
- 7.6.4 Saudi Arabia
- 7.6.5 UAE
- 7.6.6 Israel
- 7.6.7 South Africa
- 7.6.8 Rest of the Middle East And Africa
Chapter 8. COMPETITIVE LANDSCAPE
- 8.1. Recent Developments
- 8.2. Company Categorization
- 8.3. Supply Chain & Channel Partners (based on availability)
- 8.4. Market Share & Positioning Analysis (based on availability)
- 8.5. Vendor Landscape (based on availability)
- 8.6. Strategy Mapping
Chapter 9. COMPANY PROFILES OF GLOBAL RECOMBINANT FACTOR C ASSAY INDUSTRY
- 9.1. Top Companies Market Share Analysis
- 9.2. Company Profiles
- 9.2.1 Thermo Fisher Scientific Inc
- 9.2.2 Lonza Group AG
- 9.2.3 WuXi AppTec Co. Ltd
- 9.2.4 Merck KGaA
- 9.2.5 Charles River Laboratories International Inc
- 9.2.6 Sartorius AG
- 9.2.7 Eurofins Scientific
- 9.2.8 GenScript Biotech Corporation
- 9.2.9 Agilent Technologies Inc
- 9.2.10 PerkinElmer Inc
- 9.2.11 Tecan Group Ltd
- 9.2.12 Bio-Rad Laboratories Inc
- 9.2.13 Beckman Coulter Inc
- 9.2.14 Abcam Plc
- 9.2.15 Hycult Biotech
